Article
Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt.
Alimentary pharmacology & therapeutics - 1 Mar 2017
Elsharkawy A, Fouad R, El Akel W, El Raziky M, Hassany M, Shiha G, Said M, Motawea I, El Demerdash T, Seif S, Gaballah A, El Shazly Y, Makhlouf M A M, Waked I, Abdelaziz A O, Yosry A, El Serafy M, Thursz M, Doss W, Esmat G
Abstract excerpt
BACKGROUND: Chronic hepatitis C virus infection is one of the most important health problems in Egypt. The Ministry of Health's National Treatment Programme introduced sofosbuvir-based therapy in October 2014. AIM: To assess the clinical effectiveness and predictors of response to SOF-based treatment regimens, either dual therapy, with SOF/ribavirin (RBV) for 6 months or triple therapy with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.